- Apps show where travelers exercise most — and least — on vacation
- Schott Pharma shares climb in Frankfurt debut
- AstraZeneca, Bristol Myers Squibb to participate in Medicare drug price negotiations
- Ozempic, Wegovy drug prescriptions hit 9 million, surge 300% in under three years
- Miami man pleads guilty to selling adulterated, misbranded HIV drugs across U.S.
- Working women spend $15.4 billion more than men in out-of-pocket health costs, study finds
- Pfizer restarts production at tornado-hit North Carolina plant, but drug supply will still be affected
- Merck Covid drug linked to virus mutations that can spread between people, new study says
- CDC recommends Pfizer maternal RSV vaccine to protect infants, paving way for fall availability
- More than 75,000 Kaiser Permanente workers threaten strike if labor agreement not reached
- Health care has had a tough year. Where we stand on our 5 stocks in the sector
- Providers struggle to get latest Covid shots into arms amid early supply issues
- FTC sues Texas anesthesiology provider to bust monopoly
- Here's a rapid-fire update on all 35 stocks in the Club's portfolio, including a new buy
- Florida nurse practitioner convicted in $200 million Medicare fraud scheme
